These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23636647)

  • 1. A survey of Canadian cancer patients' perspectives on the characteristics and treatment of breakthrough pain.
    Bedard G; Hawley P; Zhang L; Slaven M; Gagnon P; Bisland S; Bennett M; Tardif F; Chow E
    Support Care Cancer; 2013 Sep; 21(9):2557-63. PubMed ID: 23636647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough cancer pain: a comparison of surveys with European and Canadian patients.
    Bedard G; Davies A; McDonald R; Hawley P; Buchanan A; Popovic M; Wong E; Chow E
    Support Care Cancer; 2015 Mar; 23(3):791-6. PubMed ID: 25193599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids for the management of breakthrough pain in cancer patients.
    Zeppetella G; Davies AN
    Cochrane Database Syst Rev; 2013 Oct; (10):CD004311. PubMed ID: 24142465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Canadian online survey of oncology nurses' perspectives on the management of breakthrough pain in cancer (BTPc).
    Fitch MI; McAndrew A; Burlein-Hall S
    Can Oncol Nurs J; 2013; 23(1):28-43. PubMed ID: 23617217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of breakthrough cancer pain].
    Sláma O
    Klin Onkol; 2013; 26(3):191-4. PubMed ID: 23763322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based treatment of cancer-related breakthrough pain with opioids.
    Zeppetella G
    J Natl Compr Canc Netw; 2013 Mar; 11 Suppl 1():S37-43. PubMed ID: 23520185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
    Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences of cancer patients with breakthrough pain and pharmacological treatments].
    Bertram L; Stiel S; Elsner F; Radbruch L; Davies A; Nauck F; Alt-Epping B
    Schmerz; 2010 Dec; 24(6):605-12. PubMed ID: 21046170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A report on the long-term use of fentanyl pectin nasal spray in patients with recurrent breakthrough pain.
    Taylor D; Radbruch L; Revnic J; Torres LM; Ellershaw JE; Perelman M
    J Pain Symptom Manage; 2014 Jun; 47(6):1001-7. PubMed ID: 24128821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of barriers to pain management in patients receiving outpatient palliative care.
    Kwon JH; Hui D; Chisholm G; Hong WT; Nguyen L; Bruera E
    J Palliat Med; 2013 Aug; 16(8):908-14. PubMed ID: 23758527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
    Masel EK; Landthaler R; Gneist M; Watzke HH
    Support Care Cancer; 2018 Feb; 26(2):491-497. PubMed ID: 28849261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities Between Clinician and Patient Perception of Breakthrough Pain Control.
    Webber K; Davies AN; Cowie MR
    J Pain Symptom Manage; 2016 May; 51(5):933-937.e2. PubMed ID: 26740387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
    Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
    Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Canadian online survey of oncology nurses' perspectives on the defining characteristics and assessment of breakthrough pain in cancer.
    Fitch MI; McAndrew A; Burlein-Hall S
    Can Oncol Nurs J; 2013; 23(2):85-99. PubMed ID: 23847840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough pain in elderly patients with cancer: treatment options.
    Pautex S; Vogt-Ferrier N; Zulian GB
    Drugs Aging; 2014 Jun; 31(6):405-11. PubMed ID: 24817569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies.
    Davies A; Zeppetella G; Andersen S; Damkier A; Vejlgaard T; Nauck F; Radbruch L; Sjolund KF; Stenberg M; Buchanan A
    Eur J Pain; 2011 Aug; 15(7):756-63. PubMed ID: 21251860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
    Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
    Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
    [No Abstract]   [Full Text] [Related]  

  • 20. Fentanyl for breakthrough cancer pain: where are we?
    Meriggi F; Zaniboni A
    Rev Recent Clin Trials; 2013 Mar; 8(1):42-7. PubMed ID: 23259417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.